Parkinson's disease: in vivo metabolic changes in the frontal and parietal cortices in 6-OHDA treated rats during different periods
- PMID: 23931110
- DOI: 10.3109/00207454.2013.825616
Parkinson's disease: in vivo metabolic changes in the frontal and parietal cortices in 6-OHDA treated rats during different periods
Abstract
This study aims to investigate metabolic changes in frontal and parietal cortices in the 6-OHDA induced Parkinson's rats. Ratios of N-acetyl-aspartic acid/creatine (NAA/Cr), choline/creatine (Cho/Cr), and glumatic acid and glutamine glutaminic acid/creatine (Glx/Cr) of regions of interests (ROIs) in the frontal and parietal cortices, and the substantia nigra were analyzed. NAA/Cr, Cho/Cr and Glx/Cr in the frontal and parietal cortices in the lesion side did not show any significant differences two weeks after operation compared with the contralateral side (p > 0.05). NAA/Cr in the frontal cortex in the lesion side was significantly lower in the five weeks after operation; Cho/Cr remained normal; Glx/Cr increased (p < 0.05), and all ratios of parietal cortex were normal. In the eight weeks after operation, NAA/Cr in the frontal cortex in the lesion side was lower than that of the five weeks (p < 0.01), Cho/Cr still remained normal while Glx/Cr was higher than before (p < 0.01). Regarding the parietal cortex, NAA/Cr increased significantly, while Cho/Cr and Glx/Cr remained normal. In the 12 weeks after operation, NAA/Cr, Cho/Cr and Glx/Cr in frontal cortex were consistent with that of the eight weeks, while they remained at the normal level in parietal cortex. The NAA/Cr in the substantia nigra decreased and Cho/Cr increased significantly during 2-8 weeks, and remained at the same level during 8-12 weeks. There are metabolic disturbances in PD rats. The transient hyperfunction in the parietal cortex can be considered as a compensation for the dysfunction of the frontal cortex and substantia nigra.
Similar articles
-
Neural metabolite changes in corpus striatum after rat multipotent mesenchymal stem cells transplanted in hemiparkinsonian rats by magnetic resonance spectroscopy.Int J Neurosci. 2013 Dec;123(12):883-91. doi: 10.3109/00207454.2013.814132. Epub 2013 Aug 1. Int J Neurosci. 2013. PMID: 23768098
-
A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease.Metab Brain Dis. 1999 Mar;14(1):45-55. doi: 10.1023/a:1020609530444. Metab Brain Dis. 1999. PMID: 10348313
-
Effect of creatine supplementation on metabolite levels in ALS motor cortices.Exp Neurol. 2001 Dec;172(2):377-82. doi: 10.1006/exnr.2001.7797. Exp Neurol. 2001. PMID: 11716561
-
Proton magnetic resonance spectroscopy of the human brain in schizophrenia.Rev Neurosci. 2000;11(2-3):147-58. doi: 10.1515/revneuro.2000.11.2-3.147. Rev Neurosci. 2000. PMID: 10718151 Review.
-
N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration.Schizophr Res. 2005 Mar 1;73(2-3):209-19. doi: 10.1016/j.schres.2004.02.001. Schizophr Res. 2005. PMID: 15653263 Review.
Cited by
-
Altered prefrontal neurochemistry in the DJ-1 knockout mouse model of Parkinson's disease: complementary semi-quantitative analyses with in vivo magnetic resonance spectroscopy and MALDI-MSI.Anal Bioanal Chem. 2022 Nov;414(28):7977-7987. doi: 10.1007/s00216-022-04341-8. Epub 2022 Oct 8. Anal Bioanal Chem. 2022. PMID: 36208327
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources